Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma
by
Covey, Anne
, Maluccio, Mary
in
Algorithms
/ Cancer
/ Medical diagnosis
/ Medical treatment
2012
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma
by
Covey, Anne
, Maluccio, Mary
in
Algorithms
/ Cancer
/ Medical diagnosis
/ Medical treatment
2012
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma
Journal Article
Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma
2012
Request Book From Autostore
and Choose the Collection Method
Overview
Hepatocellular carcinoma (HCC) is one of the few cancers in which a continued increase in incidence has been observed over several years. As such, there has been a focus on safe and accurate diagnosis and the development of treatment algorithms that take into consideration the unique complexities of this patient population. In the past decade, there have been improvements in nonsurgical treatment platforms and better standardization with respect to the diagnosis and patient eligibility for liver transplant. How to navigate patients through the challenges of treatment is difficult and depends on several factors: 1) patient-related variables such as comorbid conditions that influence treatment eligibility; 2) liver-related variables such as Child-Pugh score; and 3) tumor-related variables such as size, number, pattern of spread within the liver, and vascular involvement. The objectives of this review are to put into perspective the current treatment options for patients with HCC, the unique advantages and disadvantages of each treatment approach, and the evidence that supports the introduction of sorafenib into the multidisciplinary management of HCC. [PUBLICATION ABSTRACT]
Publisher
Wiley Subscription Services, Inc
Subject
This website uses cookies to ensure you get the best experience on our website.